Stockscreener 앱 받기
6.60
1.69%
0.11
전일 마감가:
$6.49
열려 있는:
$6.55
하루 거래량:
13,845
Relative Volume:
0.28
시가총액:
$201.19M
수익:
$4.01M
순이익/손실:
$-35.01M
주가수익비율:
-7.0213
EPS:
-0.94
순현금흐름:
$-24.53M
1주 성능:
-5.31%
1개월 성능:
-12.81%
6개월 성능:
-24.49%
1년 성능:
+85.39%
1일 변동 폭
$6.44
$6.85
1주일 범위
$6.36
$7.17
52주 변동 폭
$3.51
$9.96
Xbiotech Inc Stock (XBIT) Company Profile
명칭
Xbiotech Inc
전화
512-386-2900
주소
5217 WINNEBAGO LANE, AUSTIN, TX
XBIT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| XBIT | 6.60 | 201.19M | 4.01M | -35.01M | -24.53M | -0.94 |
| VRTX | 450.44 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 749.43 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.59 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.53 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.84 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-06-14 | 개시 | Piper Jaffray | Overweight |
| 2017-04-21 | 다운그레이드 | Noble Financial | Buy → Hold |
| 2016-06-28 | 재확인 | Noble Financial | Buy |
Xbiotech Inc 주식(XBIT)의 최신 뉴스
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat
Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR
How To Trade (XBIT) - Stock Traders Daily
XBiotech: Q3 Earnings Snapshot - New Haven Register
Transforming lives for those battling cancer with the speed & precision of AIRakovina Therapeutics (TSXV: RKV) | GCFF - NAI 500
XBiotech (NASDAQ:XBIT) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
XBiotech Inc.'s (NASDAQ:XBIT) 12% gain last week benefited both individual investors who own 49% as well as insiders - Simply Wall St
(XBIT) Technical Data - Stock Traders Daily
XBiotech (NASDAQ:XBIT) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
(XBIT) Technical Pivots with Risk Controls - Stock Traders Daily
Desmoplastic Small Round Cell Tumor Treatment Market Overall - openPR
XBiotech (NASDAQ:XBIT) Stock Passes Above 50 Day Moving AverageShould You Sell? - MarketBeat
How the (XBIT) price action is used to our Advantage - Stock Traders Daily
Enerflex Ltd. (NYSE:EFXT) Stake Increased by The Manufacturers Life Insurance Company - Defense World
Alopecia Areata Market Analysis, Size, Market Report 2024-2033 - WhaTech
76,460 Shares in XBiotech Inc. (NASDAQ:XBIT) Acquired by American Century Companies Inc. - Defense World
American Century Companies Inc. Acquires Shares of 76,460 XBiotech Inc. (NASDAQ:XBIT) - MarketBeat
Cancer Antigen Market Size Is Booming Worldwide with Share, Size, Top Key Players - Talented India
Rhumbline Advisers Has $103,000 Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
Rhumbline Advisers Has $335,000 Stock Position in The First of Long Island Co. (NASDAQ:FLIC) - Defense World
Bank of New York Mellon Corp Buys 49,863 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech (NASDAQ:XBIT) vs. Harmony Biosciences (NASDAQ:HRMY) Financial Contrast - Defense World
XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.63 - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Above 50-Day Moving Average of $6.63 - MarketBeat
Objective long/short (XBIT) Report - Stock Traders Daily
XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving Average of $6.47 - MarketBeat
XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.47 - Defense World
Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load? - Simply Wall St
Hidradenitis Suppurativa Market Demand, Share, Size, Trends, Forecast To 2033 - WhaTech
Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - GlobeNewswire Inc.
XBiotech Inc. (NASDAQ:XBIT) Stock Holdings Increased by Vanguard Group Inc. - Defense World
XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.22 - MarketBeat
XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.22 - Defense World
XBiotech: Q2 Earnings Snapshot - CT Insider
XBIT Stock Earnings: XBiotech Reported Results for Q2 2024 - InvestorPlace
(XBIT) Trading Signals - Stock Traders Daily
XBiotech (NASDAQ:XBIT) Stock Crosses Above 50 Day Moving Average of $6.35 - Defense World
XBiotech Inc. (NASDAQ:XBIT) most popular amongst retail investors who own 51%, insiders hold 35% - Yahoo Finance
XBiotech (NASDAQ:XBIT) Stock Crosses Above 50-Day Moving Average of $6.35 - MarketBeat
(XBIT) Investment Analysis - Stock Traders Daily
XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest - MarketBeat
XBiotech Inc. (NASDAQ:XBIT) Shares Acquired by Empowered Funds LLC - Defense World
XBiotech Inc. (NASDAQ:XBIT) Sees Large Decrease in Short Interest - Defense World
XBiotech Inc. (NASDAQ:XBIT) Short Interest Update - MarketBeat
Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts - GlobeNewswire
Long Term Trading Analysis for (XBIT) - Stock Traders Daily
XBiotech Inc. (NASDAQ:XBIT) surges 26%; individual investors who own 51% shares profited along with insiders - Simply Wall St
XBiotech (NASDAQ:XBIT) Shares Pass Below 50-Day Moving Average of $7.29 - MarketBeat
XBiotech (NASDAQ:XBIT) Share Price Crosses Below 50 Day Moving Average of $7.29 - Defense World
Xbiotech Inc (XBIT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):